✨ Medicines Distribution Consents




27 OCTOBER 2005 NEW ZEALAND GAZETTE, No. 180

4557

Product:
Lipex
Active Ingredient:
Simvastatin 40mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
Merck & Co Inc, West Point, Pennsylvania, United States of America
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Product:
Lipex
Active Ingredient:
Simvastatin 5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
Merck & Co Inc, West Point, Pennsylvania, United States of America
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia

Product:
Lipex
Active Ingredient:
Simvastatin 80mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer:
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom

Dated this 20th day of October 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7178

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new related product set out in the Schedule hereto:

Schedule
Product:
Colgate Fluoride Toothpaste for Kids - Sparkling Mint Gel Ages 2-6
Active Ingredient:
Sodium monofluorophosphate 0.304%w/w equivalent to fluoride ion 400ppm
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer:
Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia

Dated this 21st day of October 2005.

MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7180

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:

Schedule
Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 12.495mg equivalent to citalopram 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India

Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India

Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 49.98mg equivalent to citalopram 40mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 180


Gazette.govt.nz PDF NZ Gazette 2005, No 180





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of Changed Medicine (continued from previous page)

πŸ₯ Health & Social Welfare
20 October 2005
Medicines Act, Lipex, Simvastatin, Merck Sharp & Dohme
  • DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001)

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
21 October 2005
Medicines Act, Colgate Fluoride Toothpaste, Sodium monofluorophosphate, Colgate-Palmolive
  • MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001)

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act, Citalopram, Rex Medical, Cipla Limited